Preventive antibiotics in stroke study: Rationale and protocol for a randomised trial

International Journal of Stroke

Volumn 6, Issue 2, 2011, Pages 159-163

  Nederkoorn, Paul J ^a   Westendorp, Willeke F ^a   Hooijenga, Imke J ^a   de Haan, Rob J ^a   Dippel, Diederik W J ^a   Vermeij, Frederique H ^a   Dijkgraaf, Marcel G W ^a   Prins, Jan M ^a,b   Spanjaard, Lodewijk ^b,c   van de Beek, Diederik ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Antibiotics; Infection; Pneumonia; Prevention; Stroke

Indexed keywords

CEFTRIAXONE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; FEVER; FOLLOW UP; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION; INFECTION RATE; LENGTH OF STAY; MULTICENTER STUDY (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; STROKE; STROKE PATIENT; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFTRIAXONE; HUMANS; RECOVERY OF FUNCTION; RESEARCH DESIGN; STROKE;

EID: 79952304255     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00555.x     Document Type: Article

References (21)

1. van der Worp HB, van Gijn J. Acute ischemic stroke. N Engl J Med 2007; 357:572-9.
2. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-74.
3. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7:341-53.
4. Thone-Reineke C, Neumann C, Namsolleck P et al. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J Hypertens 2008; 26:2426-35.
5. van de Beek D, Wijdicks EF, Vermeij FH et al. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol 2009; 66:1076-81.
6. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115:e478-534.
7. Stichting Werkgroep Antibiotica Beleid (SWAB) guidelines. Available at (last accessed 22 November 2010).
8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
9. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007; 38:1091-6.
10. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005; 36:2756-63.
11. Sharma JC, Fletcher S, Vassallo M, Ross I. What influences outcome of stroke - pyrexia or dysphagia? Int J Clin Pract 2001; 55:17-20.
12. Hamidon BB, Nabil I, Raymond AA. Risk factors and outcome of dysphagia after an acute ischaemic stroke. Med J Malaysia 2006; 61:553-7.
13. McHugh GS, Butcher I, Steyerberg EW et al. Statistical Approaches to the Univariate Prognostic Analysis of the IMPACT Database on Traumatic Brain Injury. J Neurotrauma 2007; 24:251-8.
14. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344:665-671.
15. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328-34.
16. Lee SG, Su ZZ, Emdad L et al. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 2008; 283:13116-23.
17. Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 2007; 146:617-29.
18. Harms H, Prass K, Meisel C et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008; 3:e2158.
19. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62 (Suppl. 1): i1-9.
20. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2008. Available at (last accessed 22 November 2010).
21. Livermore DM, Canton R, Gniadkowski M et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59:165-74.